Awards & Advancement

Susan Stansfield named executive VP, clinical development at Premier Research

Friday, January 13, 2012 12:03 PM

Premier Research Group has named Susan C. Stansfield, Ph.D., its new executive vice president of clinical development.

More... »

Pharmaceutical Institute integrates Preceptiv Learning Solutions

Friday, January 13, 2012 12:00 PM

Pharmaceutical Institute has now fully integrated Preceptiv Learning Solutions into its operations, both subsidiaries of inVentiv Health.

More... »

Gene Security Network changes name to Natera

Monday, January 9, 2012 01:57 PM

Gene Security Network, a preconception and prenatal genetic testing company, announced on Jan.6 its name change to Natera.

More... »

Boyle joins Bionovo

Friday, January 6, 2012 09:21 AM

Bionovo, a pharmaceutical company focusing on women’s health and cancer, has named David Boyle senior vice president and chief financial officer.

More... »

Provenance closes an $8 million financing agreement

Wednesday, December 28, 2011 01:11 PM

Provenance Biopharmaceuticals has closed an $8 million financing arrangement with Alopexx Enterprises for the continued development of anti-cancer therapeutic, DI-Leu16-IL2.

More... »

Cetero Research expands senior management team

Tuesday, December 27, 2011 11:49 AM

Cetero Research has reported two new appointments to its senior management team. Michael C. Fillios was named chief administrative officer, with leadership responsibility and oversight of human resources, information technology, project management, marketing and client services. David Coggin was named vice president, biometrics. He will oversee the operational management of PK/PD, data management, miostatistics and medical writing services.

More... »

PTC Therapeutics receives $5 million award from the Wellcome Trust

Friday, December 23, 2011 10:45 AM

PTC Therapeutics has received a $5 million Seeding Drug Discovery (SDD) award from the Wellcome Trust to support the development of small-molecule drugs that target life-threatening infections caused by multidrug-resistant (MDR) Gram-negative bacteria. PTC previously received a $5.4 million SDD Award from the Wellcome Trust to support its BMI1 oncology program.

More... »

Acceleron raises $30 million in private financing

Friday, December 23, 2011 10:32 AM

Acceleron Pharma has raised a $30M private financing. Celgene, one of Acceleron’s strategic partners, and all other existing investors participated in this financing. The proceeds will be used to expand and advance Acceleron’s clinical stage pipeline and to continue to support its highly productive research engine.

More... »

ISPE names Berg president and CEO

Thursday, December 22, 2011 12:28 PM

ISPE, the International Society for Pharmaceutical Engineering, has named Nancy S. Berg president and CEO, effective January 1, 2012.

More... »

Delcath names Gores to medical advisory board

Thursday, December 22, 2011 11:57 AM

More... »